What is the price-to-earnings ratio of Theraclion?
The price-earnings ratio of Theraclion is currently 3.7.
Theraclion P/E 2024
Theraclion P/E
3.7
Ticker
ALTHE.PA
ISIN
FR0010120402
WKN
A112C8
As of Nov 19, 2024, Theraclion's P/E ratio was 3.7, a -155.06% change from the -6.72 P/E ratio recorded in the previous year.
The Theraclion P/E history
Theraclion Aktienanalyse
What does Theraclion do?
Theraclion SA is a French medical company specializing in the development and production of innovative therapy systems. The company was founded in 2004 and is headquartered in Malakoff, France. Theraclion's business model is based on the development and marketing of medical devices based on High Intensity Focused Ultrasound (HIFU) technology. This technology uses ultrasound pulses to treat targeted areas in the body without the need for surgical intervention. Theraclion specializes in three main areas: oncology, dermatology, and aesthetics. In the field of oncology, Theraclion has developed the Echopulse system, which is used for the treatment of breast tumors. The system applies high-intensity ultrasound pulses to kill tumor cells without damaging surrounding tissue. This non-invasive method of tumor treatment is very promising and has already shown promising results in several studies. In the field of dermatology, Theraclion has developed the Echovist system, which is used for the treatment of nevi (moles). The system also utilizes HIFU technology to destroy the nevi, resulting in a significant improvement in the aesthetic appearance of the skin. In the field of aesthetics, Theraclion has developed the Sonovein system, which is used for the treatment of varicose veins. The system also utilizes HIFU technology to close the veins and thus improve the patient's appearance and quality of life. Theraclion has experienced impressive growth in recent years and is now an important player in the medical industry. The company has filed several patents and works closely with leading doctors and research institutions to maximize the effectiveness of its products. Overall, Theraclion aims to offer innovative therapies that meet the needs of patients and help them lead fulfilling lives. The company is committed to continuously improving its products and services and strives to achieve even greater successes in the future. Theraclion ist eines der beliebtesten Unternehmen auf Eulerpool.com.P/E Details
Deciphering Theraclion's P/E Ratio
The Price to Earnings (P/E) Ratio of Theraclion is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.
Year-to-Year Comparison
Assessing Theraclion's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.
Impact on Investments
The P/E ratio of Theraclion is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.
Interpreting P/E Ratio Fluctuations
Fluctuations in Theraclion’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.
Frequently Asked Questions about Theraclion stock
How has the price-earnings ratio of Theraclion changed compared to last year?
The price-to-earnings ratio of Theraclion has increased by -155.06% fallen (meaning "decreased" or "dropped") compared to last year.
What consequences does a high price-earnings ratio have for investors?
A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.
What does a low price-earnings ratio mean?
A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.
Is the price-earnings ratio of Theraclion high compared to other companies?
Yes, the price-to-earnings ratio of Theraclion is high compared to other companies.
How does an increase in the price-earnings ratio of Theraclion affect the company?
An increase in the price-earnings ratio of Theraclion would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.
How does a reduction in the price-to-earnings ratio of Theraclion affect the company?
A decrease in the price-earnings ratio of Theraclion would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.
What are some factors that influence the price-earnings ratio of Theraclion?
Some factors that influence the price-earnings ratio of Theraclion are the company's growth, financial position, industry development, and the overall economic situation.
How much dividend does Theraclion pay?
Over the past 12 months, Theraclion paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Theraclion is expected to pay a dividend of 0 EUR.
What is the dividend yield of Theraclion?
The current dividend yield of Theraclion is .
When does Theraclion pay dividends?
Theraclion pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Theraclion?
Theraclion paid dividends every year for the past 0 years.
What is the dividend of Theraclion?
For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.
In which sector is Theraclion located?
Theraclion is assigned to the 'Health' sector.
Wann musste ich die Aktien von Theraclion kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Theraclion from 11/19/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 11/19/2024.
When did Theraclion pay the last dividend?
The last dividend was paid out on 11/19/2024.
What was the dividend of Theraclion in the year 2023?
In the year 2023, Theraclion distributed 0 EUR as dividends.
In which currency does Theraclion pay out the dividend?
The dividends of Theraclion are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Theraclion
Our stock analysis for Theraclion Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Theraclion Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
